To confirm the critical role of KIT in melanoma, we carried out the survival analysis based on 468 melanoma patients in TCGA database, which identified KIT as a significant biomarker negatively related to prognosis in melanoma patients (Fig. 4F). The gene discussed is KIT; the disease is melanoma.